The 100,000 Genomes Club
10 Countries Meet the Mark for National Genome Projects
10 Takeover Targets to Watch This Fall
Pace of Biopharma M&A Slows from First Half Stampede of Deals
Bioprocessing Companies Push Limits of Upstream Technologies
Goal Is to Maximize Efficiency in Bioprocess Operations
Vertex’s David Altshuler Humanizes Drug Discovery
Lessons from Vertex’s Small Molecule Drug Development Program for Cystic Fibrosis
For full access to this article login to GEN Select now.
Scaleup Issues for Single Use and Steel
- New approaches to scaleup and methods for overcoming issues that may impact or impair scaleup were two key subjects discussed at the recent Sartorius Stedim Biotech “European Upstream and Downstream Technology Forum.” Topics covered included both single-use and steel production systems, but the former led to a lot ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.